1. Home
  2. ARMP vs JUNE Comparison

ARMP vs JUNE Comparison

Compare ARMP & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • JUNE
  • Stock Information
  • Founded
  • ARMP 2016
  • JUNE 1998
  • Country
  • ARMP United States
  • JUNE Singapore
  • Employees
  • ARMP N/A
  • JUNE N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • JUNE
  • Sector
  • ARMP Health Care
  • JUNE
  • Exchange
  • ARMP Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • ARMP 73.8M
  • JUNE 83.2M
  • IPO Year
  • ARMP N/A
  • JUNE 2024
  • Fundamental
  • Price
  • ARMP $1.58
  • JUNE $9.46
  • Analyst Decision
  • ARMP Strong Buy
  • JUNE
  • Analyst Count
  • ARMP 1
  • JUNE 0
  • Target Price
  • ARMP $7.00
  • JUNE N/A
  • AVG Volume (30 Days)
  • ARMP 15.2K
  • JUNE 82.2K
  • Earning Date
  • ARMP 03-20-2025
  • JUNE 05-10-2025
  • Dividend Yield
  • ARMP N/A
  • JUNE N/A
  • EPS Growth
  • ARMP N/A
  • JUNE N/A
  • EPS
  • ARMP N/A
  • JUNE N/A
  • Revenue
  • ARMP $5,174,000.00
  • JUNE $2,903,179.00
  • Revenue This Year
  • ARMP $8.43
  • JUNE N/A
  • Revenue Next Year
  • ARMP N/A
  • JUNE N/A
  • P/E Ratio
  • ARMP N/A
  • JUNE N/A
  • Revenue Growth
  • ARMP 14.24
  • JUNE N/A
  • 52 Week Low
  • ARMP $1.58
  • JUNE $2.75
  • 52 Week High
  • ARMP $4.25
  • JUNE $9.90
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 30.25
  • JUNE N/A
  • Support Level
  • ARMP $1.63
  • JUNE N/A
  • Resistance Level
  • ARMP $2.30
  • JUNE N/A
  • Average True Range (ATR)
  • ARMP 0.15
  • JUNE 0.00
  • MACD
  • ARMP -0.04
  • JUNE 0.00
  • Stochastic Oscillator
  • ARMP 0.00
  • JUNE 0.00

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is engaged in providing design, fit-out, repair, and maintenance services for commercial and residential buildings. The design services include both the consultation with its staff and the actual design work. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, installing switches, power outlets, telephone wiring, computer outlet covers, and other electrical and wiring works. Repair and maintenance works include, among other things, replacement of fixtures and fittings, repair and maintenance of cupboards and shelves, and repainting walls and ceilings. Geographically, the company derives all of its revenue from its customers in Hong Kong.

Share on Social Networks: